Primary Site >> Colorectal Cancer

Gene >> RTN4R

Journal: Br J Cancer. 2004 Apr 19;90(8):1627-35.
Title: Improved biological activity of a mutant endostatin containing a single amino-acid substitution.
Author: Yokoyama, Y|Ramakrishnan, S
PMID: 15083196
Journal: Anticancer Drugs. 2007 Nov;18(10):1189-200.
Title: Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.
Author: Garde, Seema V|Forte, Andre J|Ge, Michael|Lepekhin, Eugene A|Panchal, Chandra J|Rabbani, Shafaat A|Wu, Jinzi J
PMID: 17893520
Journal: Eur J Cancer. 2010 Jan;46(1):198-206.
Title: Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours.
Author: Gregorc, Vanesa|Citterio, Giovanni|Vitali, Giordano|Spreafico, Anna|Scifo, Paola|Borri, Anna|Donadoni, Giovanni|Rossoni, Gilda|Corti, Angelo|Caligaris-Cappio, Federico|Del Maschio, Alessandro|Esposito, Antonio|De Cobelli, Francesco|Dell'Acqua, Flavio|Troy
PMID: 19900802
Journal: Eur J Cancer. 2010 Oct;46(15):2746-52.
Title: Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy.
Author: Santoro, Armando|Rimassa, Lorenza|Sobrero, Alberto F|Citterio, Giovanni|Sclafani, Francesco|Carnaghi, Carlo|Pessino, Anna|Caprioni, Francesco|Andretta, Valeria|Tronconi, Maria Chiara|Finocchiaro, Giovanna|Rossoni, Gloria|Zanoni, Angela|Miggiano, Chiara|Ri
PMID: 20708923
Journal: Ann Oncol. 2011 Apr;22(4):973-8.
Title: Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies.
Author: Mammoliti, S|Andretta, V|Bennicelli, E|Caprioni, F|Comandini, D|Fornarini, G|Guglielmi, A|Pessino, A|Sciallero, S|Sobrero, A F|Mazzola, G|Lambiase, A|Bordignon, C
PMID: 20855468
Journal: Brain Res. 2012 Feb 3;1436:168-77.
Title: Modifying neurorepair and neuroregenerative factors with tPA and edaravone after transient middle cerebral artery occlusion in rat brain.
Author: Deguchi, Kentaro|Miyazaki, Kazunori|Tian, Fengfeng|Liu, Ning|Liu, Wentao|Kawai, Hiromi|Omote, Yosiho|Kono, Syoichiro|Yunoki, Taijun|Deguchi, Shoko|Abe, Koji
PMID: 22221736
Journal: World J Gastroenterol. 2012 Oct 21;18(39):5551-9.
Title: MUC5AC/beta-catenin expression and KRAS gene alteration in laterally spreading colorectal tumors.
Author: Nakae, Kosaburo|Mitomi, Hiroyuki|Saito, Tsuyoshi|Takahashi, Michiko|Morimoto, Takashi|Hidaka, Yasuhiro|Sakamoto, Naoto|Yao, Takashi|Watanabe, Sumio
PMID: 23112547
Journal: Mol Imaging. 2013 May;12(3):173-81.
Title: Cerenkov luminescence tomography of aminopeptidase N (APN/CD13) expression in mice bearing HT1080 tumors.
Author: Hu, Zhenhua|Yang, Weidong|Ma, Xiaowei|Ma, Wenhui|Qu, Xiaochao|Liang, Jimin|Wang, Jing|Tian, Jie
PMID: 23490443
Journal: Jpn J Clin Oncol. 2017 Sep 1;47(9):795-808.
Title: Antitumor activity of iNGR-GRIM-19 in colorectal cancer.
Author: Pang, Li|Xia, Yan|Wang, Dawei|Meng, Xiangwei
PMID: 28903530